The images above are shown for illustration purposes only. They may not be an exact representation of the product.

NAD+ Injections

Compounded NAD+ injections are prescription sterile preparations with limited clinical evidence for wellness uses. NAD+ has a normal role in cellular metabolism, but that role does not prove benefit from injections. Confirm the purpose, route, monitoring, and ingredient suitability with your care team.

This medication requires a prescription.

Additional Information

NAD+ injections: clinical evidence and preparation questions

Nicotinamide adenine dinucleotide (NAD+) participates in cellular redox reactions and metabolism. A normal biological role does not establish that injecting more improves energy, longevity, cognition, or disease outcomes. A clinician should explain the proposed clinical purpose and alternatives before prescribing.

Which uses are established?

NAD+ infusions have been studied in small or specialized settings, including metabolism and selected disease populations. These findings do not establish a routine treatment for fatigue, aging, addiction, or a general wellness indication. Symptoms such as persistent fatigue need evaluation for their cause.

What should I ask about the prescription?

Confirm the exact ingredient, concentration, total amount, intended route, formulation, and administration setting. Do not assume an IV preparation and a subcutaneous preparation are interchangeable. Obtain appropriate administration training and ask about monitoring, storage, beyond-use date, and what to do if the product appears abnormal.

What safety issues matter?

Discuss medical conditions, pregnancy, breastfeeding, allergies, and all medicines. Sterile compounding ingredient suitability and preparation quality are essential. FDA has reported chills, shaking, vomiting, and fatigue after NAD+ injections, with reactions consistent with excessive endotoxins. Seek prompt care for severe symptoms after administration. A dietary-supplement ingredient is not automatically suitable for injection.

What does research say about NAD+?

A small 2019 IV pilot study examined changes in NAD-related metabolites; it was not proof of anti-aging or addiction-treatment benefit. A retrospective tolerability pilot has additional design limitations. Oral precursor studies do not establish injectable NAD+ outcomes.

Read FDA’s sterile-ingredient safety communication.

Related care

Our MitoCORE supplement listing addresses a different oral product, not an equivalent to NAD+ injection or proof of the same effects.

Prescription and ordering questions

A valid patient-specific prescription is required. Contact Healing Dose Compounding Pharmacy in Farmington Hills, Michigan at (855) 728-0288 to confirm ingredients, strength, availability, cost, and shipping eligibility. Follow your label for storage and beyond-use date. Compounded medications are not FDA-approved and are not automatically equivalent to approved products.

Related Healing Dose reading

References

  1. Grant, R., Berg, J., Mestayer, R., Braidy, N., Bennett, J., Broom, S., & Watson, J. (2019). A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11, 257. https://doi.org/10.3389/fnagi.2019.00257. This pilot examined IV metabolism; it does not establish clinical benefit for wellness uses or a different route.
The formulas and/or statements listed are provided for educational purposes only. They are compounding ideas that have commonly been requested by physicians, and have not been evaluated by the Food and Drug Administration. Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.
Search